The Bronchopulmonary Dysplasia Treatment Market is anticipated to be valued at USD 434.1 million in 2025 and is expected to reach USD 788.2 million by 2035, registering a CAGR of 6.1%. The bronchopulmonary dysplasia treatment market is growing steadily, driven by increasing awareness and advances in neonatal care. Bronchopulmonary dysplasia (BPD) is a chronic lung …
Continue reading “Bronchopulmonary Dysplasia Treatment Market to Reach USD 788.2M by 2035”